First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Prog

/PRNewswire/ -- The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of...

Related Keywords

United States , Japan , Boston , Massachusetts , Japanese , Monica Kleinman , Francis Collins , Audrey Gordon , Progeroid Laminopathies , Sam Berns , Leslie Gordon , Genetic Base Editing , National Institutes Of Health , Cell Tissue Bank , Research Database , International Patient Registry , Progeria International Patient Registry , Progeria Research Foundation , Diagnostics Testing Program , Japanese Ministry Of Health , Drug Administration , European Medicines Administration , Receives Japanese Approval , Processing Deficient Progeroid , Japanese Ministry , Patient Registry , Boston Children , Without Zokinvy , Executive Director , Progeria Research , Zokinvy Clinical Trial , National Institutes , Tissue Bank , Clinical Care Handbook , Principal Investigator , Hutchinson Gilford Progeria Syndrome , Acting Science Advisor , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Children , Diversity , Quity Amp Inclusion ,